Commentary: Once-daily aminoglycoside dosing: Where are we now?

Journal of Critical Care

Volumn 18, Issue 2, 2003, Pages 113-114

  Martin, Janet E ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; NEPHROTOXICITY; NOTE; OTOTOXICITY;

EID: 0037973656     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcrc.2003.50007     Document Type: Note

References (4)

1. Bacopoulou F, Markantonic SL, Pavlou E, et al: A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: Pharmacokinetics and associated outcomes. J Crit Care 2003 (in press)
2. McCormack JP: An emotional-based medicine approach to monitoring once-daily aminoglycosides. Pharmacotherapy 20:1524-1527, 2000
3. Freeman CD, Nicolau DP, Belliveau PP, et al: Once-daily dosing of aminoglycosides: Review and recommendations for clinical practice. J Antimicrob Chemother 39:677-686, 1997
4. Barclay ML, Kirkpatrick CM, Begg EJ: Once daily aminoglycoside therapy: Is it less toxic than multiple daily doses and how should it be monitored? Clin Pharmacokinet 36:89-98, 1999